中国のスキンケアおよびトリートメント市場 2023
このレポートに興味がある?
今すぐ無料サンプルを入手してください!
説明
The maintenance of skin health and prevention of skin conditions through proper skincare practices are crucial. Skincare not only shields the skin from environmental factors like UV radiation, pollution, and harsh weather conditions but also assists in managing and alleviating various skin conditions such as dryness, acne, and dermatitis. さらに, skincare plays a vital role in wound healing, radiation therapy, and minimizing the side effects of certain medications.
最新の研究によると, the skin care and treatment market in China is projected to experience significant growth. It is anticipated to increase by USD 79.0 billion during the period of 2023-2029, 複合年間成長率 (CAGR) の 9.88%. Several factors contribute to this growth, including the rising consumer awareness about skincare, increasing disposable income, and evolving lifestyles. Consumers are becoming more conscious of their skin health and are willing to invest in high-quality skincare products, which drives the demand for such products and propels the growth of the market.
This industry report provides comprehensive market estimates for the Chinese market, coupled with a detailed analysis of its types and regions. The skin care and treatment market in China can be segmented based on type into functional skincare, medical dressing, and general skincare. これらのセグメントの中では, the general skincare segment accounted for the highest revenue generation in 2022. In terms of geographic segmentation, the market is further divided into North China, 北東中国, 東中国, South Central China, Southwest China, and Northwest China.
The functional skincare market can be further classified into recombinant collagen, animal-derived collagen, hyaluronic acid, active ingredients from plants, その他. Among these subsegments, the active ingredients from plants held the largest market share in 2022. しかし, the recombinant collagen segment is expected to exhibit the highest CAGR during the forecast period. さらに, the medical dressing market has been categorized into recombinant collagen, animal-derived collagen, hyaluronic acid, その他. Among these categories, the recombinant collagen segment is projected to grow at the highest CAGR during the forecast period.
主要企業と競争環境
The skin care and treatment market in China is highly competitive, with several key players dominating the industry. These leading companies include Yunnan Botanee Bio-technology Group Co. 株式会社, L’Oréal S.A., Bloomage Biotechnology Corp. 株式会社, 企業として, Harbin Fuerjia Technology Co. 株式会社, Allmed Medical Products Co. 株式会社, Guangzhou Trauer Biotechnology Co. 株式会社, and Winner Medical Co. 株式会社.
This data-centric report emphasizes market trends, status, and outlook for each segment. With a comprehensive assessment across major geographies, this report serves as a valuable asset for existing market players, new entrants, and future investors.
このレポートを購入する理由?
Get a detailed picture of the China Skin Care and Treatment Market
Identify segments/areas to invest in over the forecast period in the China Skin Care and Treatment Market
競争環境を理解する, 市場の主要企業
Excel 形式でのシナリオ全体の分析を容易にするための市場予測.
3ヶ月間の戦略コンサルティングとリサーチサポート.
シングルユーザーライセンスに提供される印刷認証.
目次
図と表
部 1. 序章
1.1 説明
1.2 研究の目的
1.3 市場セグメント
1.4 報告書が検討された年数
1.5 通貨
1.6 主な対象者
部 2. 研究方法
部 3. エグゼクティブサマリー
部 4. 市場概況
部 5. CHINA SKIN CARE AND TREATMENT MARKET BY TYPE
5.1 Functional skincare
5.2 Medical dressing
5.3 General skincare
部 6. CHINA SKIN CARE AND TREATMENT MARKET BY REGION
6.1 北中国
6.2 北東中国
6.3 東中国
6.4 South Central China
6.5 Southwest China
6.6 Northwest China
部 7. 会社概要
7.1 Yunnan Botanee Bio-technology Group Co., 株式会社.
7.2 L’Oréal S.A.
7.3 Bloomage Biotechnology Corp., 株式会社.
7.4 企業として
7.5 Harbin Fuerjia Technology Co., 株式会社.
7.6 Allmed Medical Products Co., 株式会社.
7.7 Guangzhou Trauer Biotechnology Co., 株式会社.
7.8 Winner Medical Co., 株式会社.
免責事項
Yunnan Botanee Bio-technology Group Co., 株式会社.
L’Oréal S.A.
Bloomage Biotechnology Corp., 株式会社.
企業として
Harbin Fuerjia Technology Co., 株式会社.
Allmed Medical Products Co., 株式会社.
Guangzhou Trauer Biotechnology Co., 株式会社.
Winner Medical Co., 株式会社.
レポート属性 | 詳細 |
---|---|
市場規模 (2022) | 米ドル 95.4 十億 |
基準年 | 2022 |
予測年 | 2023-2029 |
CAGR (2023-2029) | 9.88% |
ページ | 21 |
セグメント化基準 | タイプ, 領域 |
対象地域 | 北中国, 北東中国, 東中国, South Central China, Southwest China, Northwest China |
キープレーヤー | Yunnan Botanee Bio-technology Group Co. 株式会社, L'Oréal S.A., Bloomage Biotechnology Corp. 株式会社, 企業として, Harbin Fuerjia Technology Co. 株式会社, Allmed Medical Products Co. 株式会社, Guangzhou Trauer Biotechnology Co. 株式会社, Winner Medical Co. 株式会社. |
世界の泌尿器科レーザー市場は、次の速度で増加すると推定されています。 5.6% 毎年からの期間 2023 に 2029. 泌尿器科用レーザーは特別に設計された医療機器です…
世界の傷跡管理市場, 収入の面で, の CAGR で進歩すると予想されます 5.8% 予測期間中, 2023-2029. 傷跡管理にはさまざまな技術と治療が含まれます…
フォームにご記入ください。折り返しご連絡させていただきます.